- Home
- BBIO vs BRX Comparison
BBIO vs BRX Comparison
Compare BBIO & BRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- BRX
- Stock Information
- Founded
- BBIO 2015
- BRX 2011
- Country
- BBIO United States
- BRX United States
- Employees
- BBIO N/A
- BRX N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- BRX Real Estate Investment Trusts
- Sector
- BBIO Health Care
- BRX Real Estate
- Exchange
- BBIO Nasdaq
- BRX Nasdaq
- Market Cap
- BBIO 8.0B
- BRX 8.0B
- IPO Year
- BBIO 2019
- BRX 2013
- Fundamental
- Price
- BBIO $42.78
- BRX $26.05
- Analyst Decision
- BBIO Strong Buy
- BRX Buy
- Analyst Count
- BBIO 14
- BRX 14
- Target Price
- BBIO $58.85
- BRX $30.30
- AVG Volume (30 Days)
- BBIO 3.3M
- BRX 2.2M
- Earning Date
- BBIO 07-31-2025
- BRX 07-28-2025
- Dividend Yield
- BBIO N/A
- BRX 4.42%
- EPS Growth
- BBIO N/A
- BRX 12.84
- EPS
- BBIO N/A
- BRX 1.05
- Revenue
- BBIO $127,415,000.00
- BRX $1,302,325,000.00
- Revenue This Year
- BBIO $102.05
- BRX $5.75
- Revenue Next Year
- BBIO $54.69
- BRX $4.42
- P/E Ratio
- BBIO N/A
- BRX $24.80
- Revenue Growth
- BBIO N/A
- BRX 3.87
- 52 Week Low
- BBIO $21.72
- BRX $22.29
- 52 Week High
- BBIO $45.48
- BRX $30.67
- Technical
- Relative Strength Index (RSI)
- BBIO 62.54
- BRX 55.41
- Support Level
- BBIO $39.65
- BRX $25.54
- Resistance Level
- BBIO $45.48
- BRX $26.33
- Average True Range (ATR)
- BBIO 1.56
- BRX 0.48
- MACD
- BBIO 0.15
- BRX 0.03
- Stochastic Oscillator
- BBIO 60.90
- BRX 58.00
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About BRX Brixmor Property Group Inc.
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.